WUXI BIOLOGICS (CAYMAN) INC UNS (WXXWY) Financials
WXXWY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 7.2 billion | 1.8 billion |
2023-03-31 | 1.6 billion | 412.7 million |
2022-12-31 | 7.2 billion | 1.9 billion |
2022-09-30 | ? | ? |
WXXWY Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | 108.0 million | 108.0 million |
2023-03-31 | -112.7 million | 19.4 million |
2022-12-31 | 130.6 million | 101.2 million |
2022-09-30 | ? | ? |
WXXWY Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-06-30 | 312.9 million |
2023-03-31 | 145.5 million |
2022-12-31 | 273.6 million |
2022-09-30 | ? |
WXXWY Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 1.2 billion | - | 321.0 million |
2023-03-31 | 405.4 million | - | - |
2022-12-31 | 1.3 billion | - | 237.8 million |
2022-09-30 | - | - | - |
WXXWY Shares Outstanding
WXXWY Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 1.8 million | 47.1 million | 93.8 million | 14.5 million |
2023-03-31 | 237.7 million | 18.3 million | 36.5 million | 4.5 million |
2022-12-31 | 462.1 million | 60.7 million | 108.8 million | 13.9 million |
2022-09-30 | - | - | - | - |
WXXWY Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 1.2 billion | 680.6 million |
2023-03-31 | 375.0 million | 199.0 million |
2022-12-31 | 1.2 billion | 689.6 million |
2022-09-30 | - | - |
WXXWY
Price: $3.36
52 week price:
Earnings Per Share: 0.21 USD
P/E Ratio: 15.63
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 20500
Market Capitalization: 7.5 billion